购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Antibiotic
    (1)
  • EGFR
    (1)
  • Endogenous Metabolite
    (1)
  • Virus Protease
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (4)
  • 5日内发货
    (3)
  • 6-8周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "cervical carcinoma cell"的结果
筛选
搜索结果
TargetMol产品目录中 "

cervical carcinoma cell

"的结果
  • 抑制剂&激动剂
    8
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    3
    TargetMol | Recombinant_Protein
  • 抗体抑制剂
    1
    TargetMol | Inhibitory_Antibodies
  • 天然产物
    5
    TargetMol | Natural_Products
  • Tyrphostin B44, (+) enantiomer
    酪氨酸磷酸化抑制剂AG 835
    T22450133550-37-5
    Tyrphostin B44, (+) enantiomer 是一种表皮生长因子受体 (EGFR) 激酶抑制剂,IC50 为 0.86 μM,活性低于 (-) 对映体。
    • ¥ 333
    In stock
    规格
    数量
    TargetMol | Inhibitor Sale
  • β-Aminopropionitrile
    BAPN, 3-氨基丙腈, 3-Aminopropionitrile
    T13475151-18-8
    β-Aminopropionitrile (3-Aminopropionitrile) 是赖氨酰氧化酶的特异性抑制剂。
    • ¥ 157
    In stock
    规格
    数量
  • Ganoderic acid F
    灵芝酸F
    T1136398665-15-7
    Ganoderic acid F 是一种灵芝酸。它具有抗肿瘤和抗转移的活性,与抑制血管生成和涉及细胞增殖和细胞死亡,致癌作用,氧化应激,钙信号传导和内质网应激的蛋白质改变等机制相关。
    • ¥ 993
    In stock
    规格
    数量
  • BPR1K653
    T712791192754-07-6
    BPR1K653 is a potent Aurora kinase inhibitor with potential anticancder activity. BPR1K653 specifically inhibited the activity of Aurora-A and Aurora-B kinase at low nano-molar concentrations in vitro. BPR1K653 was potent in targeting a variety of cancer cell lines regardless of the tissue origin, p53 status, or expression of MDR1. At the cellular level, BPR1K653 induced endo-replication and subsequent apoptosis in both MDR1-negative and MDR1-positive cancer cells. Importantly, it showed potent activity against the growth of xenograft tumors of the human cervical carcinoma KB and KB-derived MDR1-positive KB-VIN10 cells in nude mice. Finally, BPR1K653 also exhibited favorable pharmacokinetic properties in rats., BPR1K653 is a promising anti-cancer compound that has potential for the management of various malignancies, particularly for patients with MDR1-related drug resistance after prolonged chemotherapeutic treatments.
    • ¥ 10600
    6-8周
    规格
    数量
  • Lirilumab
    利瑞鲁单抗, ONO-4483, IPH2102
    T774231000676-41-4
    Lirilumab (IPH2102) 是一种针对杀伤性免疫球蛋白样受体抗体 KIR2D 的抗体,具有抗肿瘤活性,通过 Vav1 依赖性 NF-κB 去抑制增强自然杀伤细胞的抗 HPV+ 宫颈癌活性,可用于研究白血病、头颈部鳞状细胞癌 (SCCHN)。
    • ¥ 2320
    In stock
    规格
    数量
  • 17-Hydroxyneomatrine
    T800192306139-04-6
    17-Hydroxyneomatrine 是一种从苦参 (Sophora flavescens) 提取的化合物,有效抑制人宫颈癌Hela细胞生长,并展现抗菌、抗过敏、抗肿瘤、抗心律失常、消肿、利尿、免疫调节等多种生物活性。
    • 待询
    规格
    数量
  • Ganolucidic acid E
    TN7405114567-50-9
    Ganolucidic acid E effectively suppresses the proliferation of three human cancer cell lines: Caco-2 (colon cancer), HepG2 (hepatocellular carcinoma), and HeLa (cervical cancer).
    • 待询
    规格
    数量
  • Albiducin A
    TN90702222286-14-6
    Albiducin A 是一种在 Hymenoscyphus albidus 中发现的抗生素,拥有抗菌和抗癌特性。其对细菌和真菌的 MIC 范围为 16.7-66.7 mg mL;对小鼠成纤维细胞系 (Mouse fibroblasts L929) 和人宫颈癌细胞系 (Human cervical carcinoma cell line KB3-1) 的 IC50 分别为 6.1 和 2.7 μg mL。Albiducin A 有潜力在感染和癌症相关研究中发挥作用。
    • 待询
    规格
    数量
没有更多数据了